… ProQR to Participate in the LifeSci 2nd Annual Genetic … & CAMBRIDGE, Mass., June 28, 2022 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (the “Company”), a … will be accessible from the “Investors & Media” section of ProQR’s website ( https://www.proqr.com/ ) under “ Events ”. …
… ProQR Announces Strategic Changes to the Management Team and … said Daniel A. de Boer, chief executive officer of ProQR. “As we are moving into late stage development we are … reporting to David Rodman, MD, Executive Vice President of R&D. Aniz is an experienced ophthalmologist and has over 20 …
… ProQR Announces Webcast of Presentation at Upcoming HC … will be accessible from the “Investors & Media” section of ProQR’s website ( www.proqr.com ) under “ Events ” for approximately 30 days …
ProQR receives exclusive worldwide license for IONIS-RHO-2.5Rx, now QR-1123, for autosomal dominant retinitis pigmentosa (adRP), a rare inherited form of blindness with no approved therapy